The goal of this single arm clinical trial was to to explore the clinical feasibility and radiographic outcome of the injectable bioceramic sealer as an obturation material for primary molars with congenitally missing permanent successors. The main question it aimed to answer was: Does injectable bioceramic sealers can be used as an obturation material for primary molars with congenitally missing permanent successors? Researchers used a commercially available bioceramic sealer as a sole obturation material for pulpectomized primary molars with congenitally missing permanent successors Eligible participants underwent pulpectomy treatment and followed up at 3,6,12 and 24 months postoperatively to evaluate clinical and radiographic success.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
the root canals were obturated solely with Ceraseal bioceramic sealer
Minia University Dental Hospital
Minya, Egypt
number of participants with clinically successful treatment (Asymptomatic teeth)
* The tooth is asymptomatic, with no pain or discomfort. * Absence of tenderness upon percussion or palpation. * No evidence of pathological tooth mobility, soft tissue swelling, sinus tract formation, or purulent discharge from the gingival margin.
Time frame: 3 months postoperatively, 6 months postoperatively, 12 months postoperatively, 24 months postoperatively.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.